YOU ARE NOW LEAVING LungCancerProfiles.com
Links to all outside sites are provided as a reference to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.
Read these inspiring, true stories of people like you sharing their experiences about the impact molecular profiling has had on their fight against lung cancer.
When she was diagnosed with NSCLC 2 years ago, Zheng was a performer with the San Francisco Opera. After developing resistance to her treatments, her oncologist decided she should get tested for her molecular profile. She tested positive for the EGFR biomarker and started a new treatment plan.Read More
Tori is a wife, mother and active member of her local theater community with Stage 4 NSCLC. Since she had never smoked and does not have a family history of lung cancer, she was confused about her diagnosis and requested biomarker testing. These tests revealed Tori was ROS1-positive.Read More
Jeff was 46 years old when he was diagnosed with Stage 1b non-small cell andenocarcinoma. After undergoing surgery and chemotherapy, Jeff showed no evidence of disease; however, a regular scan later showed he had developed new tumors. At both diagnoses, his doctors tested his tumors for biomarkers, but tests showed no known biomarkers each time. Jeff is confident that he is on the best treatment for his cancer as a result of these tests.Read More
Jessica is a single mother of two boys and a criminal justice instructor at a local community college. As a young mother who had never smoked and led a relatively active and healthy lifestyle, she was surprised to learn of her diagnosis of non-small cell lung cancer. During her treatment journey, Jessica learned that she was ALK-positive.Read More
Shari is a retired kindergarten teacher, mother and grandmother, who enjoys singing and going to her grandchildren’s sporting events. She had bronchitis, but her doctors couldn’t find anything wrong until they did a CT scan and found stage-IV NSCLC. Shari started chemo but then switched treatments after she tested EGFR-positive.Read More
Bonnie was a businesswoman and president of a local petroleum distributor when she learned about her lung cancer 6 years ago. And although she was diagnosed in the pre-molecular testing era, Bonnie is in the process of getting her molecular profile. She encourages others to do the same.Read More
Jane is an active wife, mother, and grandmother whose passion is world travel. After several misdiagnoses for her chest pain and cough, a CT scan showed a mass in her left lung, and she learned she had advanced NSCLC. Following an initial course of chemo, molecular testing revealed her tumor was EGFR-positive. She is being treated with a medicine directed at that mutation.Read More
Laura is a graphic designer and artist who was diagnosed with Stage IIIB/IV adenocarcinoma in her left lung in December of 2007. After having her biopsy tissue sent for molecular testing, she learned she was EGFR-positive and is on a biomarker-directed therapy for that mutation.Read More
Tom was first diagnosed with lung cancer in 2005 while he was training for his 50th marathon. A CAT scan for another ailment revealed a spot on his lung. Five years after surgery, radiation, and chemo, the cancer returned. When Tom’s tumor was tested for biomarkers, he learned he was ALK-positive.Read More
Jill is a mother of four and a part-time sales executive who is a passionate lung cancer advocate due to a family history with the disease. After proactive annual baseline checkups, she too received a lung cancer diagnosis. Her cancer was EGFR-positive. More recently Jill recurred with advanced lung cancer, but she remains hopeful.Read More
Hear more about Bonnie and her passion for helping patients with lung cancer here.